Top Markets
Coin of the day
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
Clasificación en acciones #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
Precio por acción
$0.2219522
Última sincronización: 2025-09-11
Capitalización bursátil
$1.10B
Cambio (1 día)
0.04%
Cambio (1 año)
0.17%
País
CN
Comercio Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Ingresos de Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Ingresos en Sep 2024 TTM: $11.64B
Según los últimos informes financieros de Hubei Biocause Pharmaceutical Co., Ltd., los ingresos actuales de la empresa (TTM) son $11.64B. En 2022, la empresa obtuvo unos ingresos de $7.19B una disminución en comparación con los ingresos del año 2021, que fueron de $7.80B. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Hubei Biocause Pharmaceutical Co., Ltd. desde 2000 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
2026 (TTM) $11.64B 65.85%
2023 $7.02B -2.39%
2022 $7.19B -7.80%
2021 $7.80B 16.95%
2020 $6.67B -7.46%
2019 $7.21B 60.19%
2018 $4.50B -45.18%
2017 $8.21B 235.32%
2016 $2.45B 2,837.70%
2015 $83.33M -36.00%
2014 $130.20M -18.41%
2013 $159.58M 27.62%
2012 $125.04M -30.47%
2011 $179.84M -5.88%
2010 $191.07M 35.24%
2009 $141.29M 6.03%
2008 $133.26M 16.42%
2007 $114.46M 59.34%
2006 $71.83M 11.78%
2005 $64.26M 14.85%
2004 $55.95M 9.55%
2003 $51.07M 21.26%
2002 $42.12M -2.10%
2001 $43.02M 10.51%
2000 $38.93M 0.00%
Ingresos de empresas similares o competidoras